Australia, Dec. 25 -- Inozyme Pharma Inc., owns the trademark (2593169) for 'ENLANPPI' till Sept. 10, 2035.
Status: protected:
Registered/protected
Class: 5 [Pharmaceutical preparations and substances for the treatment of cardiovascular diseases and disorders; pharmaceutical preparations and substances for the treatment of bone diseases and disorders; pharmaceutical preparations and substances for the treatment of pathological calcification; pharmaceutical preparations and substances for the treatment of blood plasma pyrophosphate deficiency disorders; pharmaceutical preparations and substances for the treatment of kidney diseases and disorders.]
Type of Mark: Word
Date of Acceptance: Oct. 17
Registration Advertised: Dec. 24
For further details contact Gregory J. Chinlund Marshall Gerstein & Borun LLP .
The original document can be viewed at: https://search.ipaustralia.gov.au/trademarks/search/view/2593169.
Disclaimer: Curated by HT Syndication.
